BEIJING and FREMONT, Calif. — Annoroad has selected the WaferGen Bio-systems, Inc. (Nasdaq:WGBS) SmartChip platform for high-throughput target enrichment of BRCA1 and BRCA2 genes, SNP genotyping services and library quantification for next-generation sequencing (NGS). The system will provide the performance and flexibility to streamline key applications onto a single platform. NGS-based applications for cancer discovery […]
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that it has released a new version of its leading bioinformatics software platform that will address exome sequencing workflow. “We have always had a platform that was built by genomicists, for genomicists,” said Ted Briscoe, CEO of PierianDx. “True to our roots, […]
BRISBANE, Calif. and MOUNTAIN VIEW Calif.– CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of actionable diagnostic surveillance solutions for organ transplant recipients, and DNAnexus Inc., the leader in cloud-based genome informatics and data management, today announced that CareDx has selected DNAnexus’ cloud genomics platform to support its ongoing […]
SAN FRANCISCO — Illumina, Inc. (NASDAQ:ILMN) today announced Illumina Accelerator–the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry–has selected three new startups for its second funding cycle. Selected from a competitive pool of highly qualified applicants, the new startups from across the globe are spurring genomics innovation in […]
MOUNTAIN VIEW, Calif. — DNAnexus, the leader in cloud-based genome informatics and data management, today announced that the company was awarded a research and development contract by the U.S. Food and Drug Administration’s Office of Health Informatics to build precisionFDA, an open source platform for community sharing of genomic information. precisionFDA is a new approach […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced it has signed a definitive agreement to acquire GenoLogics Life Sciences Software, a developer of industry-leading laboratory information management systems (LIMS) for life sciences organizations. The acquisition strengthens Illumina’s industry leading portfolio of genetic analysis solutions. “The acquisition of GenoLogics demonstrates Illumina’s commitment to drive the adoption […]
PLEASANTON, Calif.–10X Genomics today announced immediate availability of Linked-Read data generated by the GemCode™ Platform using several NIST reference samples. NIST is the federal agency developing measurements and standards under the U.S. Department of Commerce. As part of the NIST Genome in a Bottle (GIAB) Consortium, 10X Genomics is adding to the technical infrastructure enabling […]
Oxford Gene Technology (OGT), the molecular genetics company, today announces the expansion of its portfolio of high-quality products for Next Generation Sequencing (NGS) with the addition of the SureSeq™ Ovarian Cancer Panel & SureSeq NGS Library Preparation Kit. The new products are a result of significant recent investment of OGT’s R&D and commercial capabilities in […]
San Carlos, CA – NuGEN Technologies today launched a sample preparation product that allows NGS detection of multiple changes in more than 500 individual genes implicated in cancer. The reagent kit, based on NuGEN’s Single Primer Enrichment Technology (SPET), is called the Ovation Cancer Panel 2.0 Target Enrichment System. The new kit updates NuGEN’s well-established […]
One company is pioneering advances in drug discovery. Another is transforming the way cancer is identified and tested. A third is improving the health of dairy cattle and reducing the need for small molecule antibiotics in agriculture. The inaugural startups recently graduated from Illumina Accelerator, the world’s first business accelerator charged with helping launch genomic […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
